The peritoneal metastasis mouse model shows that CAF-EV induces peritoneal tumor resistance, while inhibition of FAK-YAP effectively attenuates gastric cancer drug resistance in vitro and in vivo [96]. Here, PTK2 is linked to gastric cancer.